1. Home
  2. AIRG vs ATNM Comparison

AIRG vs ATNM Comparison

Compare AIRG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$4.37

Market Cap

47.4M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.33

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
ATNM
Founded
1995
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
45.2M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
AIRG
ATNM
Price
$4.37
$1.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$6.33
$4.00
AVG Volume (30 Days)
32.8K
137.7K
Earning Date
02-26-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,737,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$3.00
$1.03
52 Week High
$8.47
$2.41

Technical Indicators

Market Signals
Indicator
AIRG
ATNM
Relative Strength Index (RSI) 66.24 42.97
Support Level $3.88 $1.27
Resistance Level $4.10 $1.36
Average True Range (ATR) 0.17 0.07
MACD 0.02 -0.02
Stochastic Oscillator 78.59 26.00

Price Performance

Historical Comparison
AIRG
ATNM

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: